Skip to main content
Top
Published in: Digestive Diseases and Sciences 7/2011

01-07-2011 | Original Article

Septic Thrombophlebitis of the Portal Venous System: Clinical and Imaging Findings in Thirty-Three Patients

Authors: Jennifer T. Ames, Michael P. Federle

Published in: Digestive Diseases and Sciences | Issue 7/2011

Login to get access

Abstract

Aim

Our purpose was to review the clinical and imaging findings in a series of patients with septic thrombophlebitis of the portal venous system in order to define criteria that might allow more confident and timely diagnosis.

Materials and Methods

This is a retrospective case series. The clinical and imaging features were analyzed in 33 subjects with septic thrombophlebitis of the portal venous system.

Results

All 33 patients with septic thrombophlebitis of the portal venous system had pre-disposing infectious or inflammatory processes. Contrast-enhanced CT studies of patients with septic thrombophlebitis typically demonstrate an infectious gastrointestinal source (82%), thrombosis (70%), and/or gas (21%) of the portal system or its branches, and intrahepatic abnormalities such as a transient hepatic attenuation difference (THAD) (42%) or abscess (61%).

Conclusions

Septic thrombophlebitis of the portal system is often associated with an infectious source in the gastrointestinal tract and sepsis. Contrast-enhanced CT demonstrates an infectious gastrointestinal source, thrombosis or gas within the portal system or its branches, and intrahepatic abnormalities such as abscess in most cases. We report a THAD in several of our patients, an observation that was not made in prior reports of septic thrombophlebitis.
Literature
1.
go back to reference Bradbury MS, et al. Mesenteric venous thrombosis: diagnosis and noninvasive imaging. Radiographics. 2002;22:527–541.PubMed Bradbury MS, et al. Mesenteric venous thrombosis: diagnosis and noninvasive imaging. Radiographics. 2002;22:527–541.PubMed
2.
go back to reference Balthazar EJ, Gollapudi P. Septic thrombophlebitis of the mesenteric and portal veins: CT imaging. J Comput Assist Tomogr. 2000;24:755–760.PubMedCrossRef Balthazar EJ, Gollapudi P. Septic thrombophlebitis of the mesenteric and portal veins: CT imaging. J Comput Assist Tomogr. 2000;24:755–760.PubMedCrossRef
4.
go back to reference Slovis TL, et al. Complicated appendiceal inflammatory disease in children: pylephlebitis and liver abscess. Radiology. 1989;171:823–825.PubMed Slovis TL, et al. Complicated appendiceal inflammatory disease in children: pylephlebitis and liver abscess. Radiology. 1989;171:823–825.PubMed
5.
go back to reference Plemmons RM, Dooley DP, Longfield RN. Septic thrombophlebitis of the portal vein (pylephlebitis): diagnosis and management in the modern era. Clin Infect Dis. 1995;21:1114–1120.PubMedCrossRef Plemmons RM, Dooley DP, Longfield RN. Septic thrombophlebitis of the portal vein (pylephlebitis): diagnosis and management in the modern era. Clin Infect Dis. 1995;21:1114–1120.PubMedCrossRef
6.
go back to reference Witte CL, et al. Protean manifestations of pylethrombosis. A review of thirty-four patients. Ann Surg. 1985;202:191–202.PubMedCrossRef Witte CL, et al. Protean manifestations of pylethrombosis. A review of thirty-four patients. Ann Surg. 1985;202:191–202.PubMedCrossRef
7.
go back to reference Mathieu D, Vasile N, Grenier P. Portal thrombosis: dynamic CT features and course. Radiology. 1985;154:737–741.PubMed Mathieu D, Vasile N, Grenier P. Portal thrombosis: dynamic CT features and course. Radiology. 1985;154:737–741.PubMed
8.
go back to reference Itai Y, Moss AA, Goldberg HI. Transient hepatic attenuation difference of lobar or segmental distribution detected by dynamic computed tomography. Radiology. 1982;144:835–839.PubMed Itai Y, Moss AA, Goldberg HI. Transient hepatic attenuation difference of lobar or segmental distribution detected by dynamic computed tomography. Radiology. 1982;144:835–839.PubMed
9.
go back to reference Lim GM, et al. Septic thrombosis of the portal vein: CT and clinical observations. J Comput Assist Tomogr. 1989;13:656–658.PubMedCrossRef Lim GM, et al. Septic thrombosis of the portal vein: CT and clinical observations. J Comput Assist Tomogr. 1989;13:656–658.PubMedCrossRef
10.
go back to reference Graham GA, Bernstein RB, Gronner AT. Gas in the portal and inferior mesenteric veins caused by diverticulitis of the sigmoid colon. Report of a case with survival. Radiology. 1975;114:601–602.PubMed Graham GA, Bernstein RB, Gronner AT. Gas in the portal and inferior mesenteric veins caused by diverticulitis of the sigmoid colon. Report of a case with survival. Radiology. 1975;114:601–602.PubMed
11.
go back to reference Tublin ME, Dodd GD 3rd, Baron RL. Benign and malignant portal vein thrombosis: differentiation by CT characteristics. AJR Am J Roentgenol. 1997;168:719–723.PubMed Tublin ME, Dodd GD 3rd, Baron RL. Benign and malignant portal vein thrombosis: differentiation by CT characteristics. AJR Am J Roentgenol. 1997;168:719–723.PubMed
12.
go back to reference Harbin WP, Robert NJ, Ferrucci JT Jr. Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis. Radiology. 1980;135:273–283.PubMed Harbin WP, Robert NJ, Ferrucci JT Jr. Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis. Radiology. 1980;135:273–283.PubMed
Metadata
Title
Septic Thrombophlebitis of the Portal Venous System: Clinical and Imaging Findings in Thirty-Three Patients
Authors
Jennifer T. Ames
Michael P. Federle
Publication date
01-07-2011
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2011
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1533-6

Other articles of this Issue 7/2011

Digestive Diseases and Sciences 7/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.